Background: Blood transfusion is a traditional treatment for β-thalassemia (β-thal) that
improves the patients' anemia and lifespan, but it may lead to iron overload in parenchymal …

Beta-thalassemia (BTH), a recessively inherited haemoglobin (Hb) disorder, causes iron
overload (IO), extra-medullary haematopoiesis and bone marrow expansion with major …

To date, there is no consensus on the most reliable marker of iron status in patients with
chronic kidney disease (CKD). Serum ferritin is used routinely, although it may be a …

Thalassemia is a hereditary blood disorder characterized by reduced hemoglobin
production, leading to chronic anemia. A major complication of thalassemia management is …

Conclusion: Early diagnosis and management of EMH compressing the spinal cord are
essential to prevent permanent neurological damage. Diagnosis should be suspected …

Background Although beta thalassemia major (BTM) patients are properly treated with blood
transfusions in accompany with iron chelation therapy, they suffer from complications, such …

Background β-thalassemia intermedia (TI) spans a wide spectrum of severity and carries
higher morbidity than previously recognized, including extramedullary hematopoiesis, leg …

COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case
progression and literature review - Okar - 2020 - Clinical Case Reports - Wiley Online …

Thalassemia is a hematologic disorder caused by genetic mutation resulting in impaired
hemoglobin chain production. Patients with thalassemia commonly experience …

Purpose GH deficit (GHD) could represent an endocrine issue in ß-Thalassemia Major
(ßTM) patients. GH/IGF-1 axis has not been extensively explored in ßTM adults, so far. We …